发明名称 Antibody-endostatin fusion protein and its variants
摘要 Methods of inhibiting the growth of tumors comprising administering chimeric fusion molecules comprising endostatin mutants and all or a portion of anti-Her2 or anti-EGFR antibodies.
申请公布号 US9611313(B2) 申请公布日期 2017.04.04
申请号 US201414254333 申请日期 2014.04.16
申请人 UNIVERSITY OF MIAMI 发明人 Shin Seung-Uon;Rosenblatt Joseph David;Morrison Sherie L.
分类号 A61K39/385;C07K14/78;A61K45/06;G01N33/574;C07K16/28;C07K16/32;A61K31/00;A61K39/00;A61K38/00 主分类号 A61K39/385
代理机构 Marshall, Gerstein & Borun LLP 代理人 Marshall, Gerstein & Borun LLP
主权项 1. A method comprising the steps of: a) obtaining a biopsy sample of a tumor from a subject; b) contacting the biopsy sample with a chimeric fusion molecule comprising an anti-tumor antigen binding domain from an anti-HER2 antibody or anti-EGFR antibody and at least one human endostatin protein or fragment thereof, wherein the at least one human endostatin protein or fragment thereof comprises a proline to alanine amino acid substitution at position 125 of human endostatin, and (c) detecting vasculogenic mimicry in the biopsy sample.
地址 Miami FL US
您可能感兴趣的专利